Yuhan Corp Preferred Market Cap ($45.29 Million)
Market Cap & Net Worth: Yuhan Corp Preferred (000105)
Yuhan Corp Preferred market cap. Yuhan Corp Preferred (KO:000105) has a market capitalization of $45.29 Million (₩66.83 Billion) as of November 3, 2026. Listed on the KO stock exchange, this Korea-based company holds position #22106 globally and #1384 in its home market, demonstrating a -2.35% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Yuhan Corp Preferred's stock price ₩58200.00 by its total outstanding shares 1148340 (1.15 Million). Also see 000105 operating cash flow for how efficiently the company converts equity into cash flow.
Yuhan Corp Preferred Market Cap History (2015–2026)
Yuhan Corp Preferred market cap history from 2015 to 2026. Data shows growth from $17.65 Million to $51.13 Million (11.41% CAGR). Check Yuhan Corp Preferred share price for real-time trading data and today's change.
Yuhan Corp Preferred Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Yuhan Corp Preferred's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore Yuhan Corp Preferred (000105) equity growth momentum to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
0.00x
Yuhan Corp Preferred's market cap is 0.00 times its annual revenue
Latest Price to Earnings (P/E) Ratio
0.00x
Yuhan Corp Preferred's market cap is 0.00 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $17.16 Million | $1.32 Trillion | $161.25 Billion | 0.00x | 0.00x |
| 2017 | $21.72 Million | $1.46 Trillion | $109.03 Billion | 0.00x | 0.00x |
| 2018 | $23.17 Million | $1.52 Trillion | $57.48 Billion | 0.00x | 0.00x |
| 2019 | $26.88 Million | $1.48 Trillion | $40.01 Billion | 0.00x | 0.00x |
| 2020 | $48.18 Million | $1.62 Trillion | $192.76 Billion | 0.00x | 0.00x |
| 2021 | $43.30 Million | $1.69 Trillion | $102.58 Billion | 0.00x | 0.00x |
| 2022 | $42.49 Million | $1.78 Trillion | $95.14 Billion | 0.00x | 0.00x |
| 2023 | $49.42 Million | $1.86 Trillion | $136.20 Billion | 0.00x | 0.00x |
| 2024 | $80.86 Million | $2.07 Trillion | $70.69 Billion | 0.00x | 0.00x |
| 2025 | $78.83 Million | $2.19 Trillion | $194.08 Billion | 0.00x | 0.00x |
Competitor Companies of 000105 by Market Capitalization
Companies near Yuhan Corp Preferred in the global market cap rankings as of November 3, 2026. Also see how large is Yuhan Corp Preferred's balance sheet for a full breakdown of the balance sheet.
Key companies related to Yuhan Corp Preferred by market ranking:
- Takeda Pharmaceutical Co Ltd ADR (NYSE:TAK): Ranked #516 globally with a market cap of $52.60 Billion USD.
- GALDERMA GROUP AG (NYSE:GALDY): Ranked #536 globally with a market cap of $50.42 Billion USD.
- Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #591 globally with a market cap of $45.45 Billion USD ( CN¥310.59 Billion CNY).
- Takeda Pharmaceutical Company Limited (F:TKDA): Ranked #618 globally with a market cap of $43.60 Billion USD ( €37.29 Billion EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #516 | Takeda Pharmaceutical Co Ltd ADR | NYSE:TAK | $52.60 Billion | $16.65 |
| #536 | GALDERMA GROUP AG | NYSE:GALDY | $50.42 Billion | $46.55 |
| #591 | Jiangsu Hengrui Medicine Co Ltd | SHG:600276 | $45.45 Billion | CN¥48.69 |
| #618 | Takeda Pharmaceutical Company Limited | F:TKDA | $43.60 Billion | €18.50 |
Market Capitalization of Yuhan Corp Preferred (2015–2026)
Market capitalization of Yuhan Corp Preferred from 2015 to today. Between 2015 and today, Yuhan Corp Preferred's market cap moved from $17.65 Million to $ 51.13 Million, with a yearly change of 11.41%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | ₩51.13 Million | -35.14% |
| 2025 | ₩78.83 Million | -2.50% |
| 2024 | ₩80.86 Million | +63.62% |
| 2023 | ₩49.42 Million | +16.30% |
| 2022 | ₩42.49 Million | -1.86% |
| 2021 | ₩43.30 Million | -10.14% |
| 2020 | ₩48.18 Million | +79.24% |
| 2019 | ₩26.88 Million | +16.02% |
| 2018 | ₩23.17 Million | +6.66% |
| 2017 | ₩21.72 Million | +26.62% |
| 2016 | ₩17.16 Million | -2.81% |
| 2015 | ₩17.65 Million | -- |
End of Day Market Cap According to Different Sources
On Jul 11th, 2026 the market cap of Yuhan Corp Preferred was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $45.29 Million USD |
| MoneyControl | $45.29 Million USD |
| MarketWatch | $45.29 Million USD |
| marketcap.company | $45.29 Million USD |
| Reuters | $45.29 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Yuhan Corp Preferred
Yuhan Corporation operates as a pharmaceutical company in South Korea and internationally. It offers manufacturing services, such as custom manufacturing; process research and development of active pharmaceutical products (APIs) and intermediates; kilo and pilot-scale production of APIs and intermediates; commercial production of APIs and intermediates; production of chemical specialties; and ana… Read more